T2 BIOSYSTEMS INC (TTOO)
US89853L3024 - Common Stock
T2 BIOSYSTEMS INC
NASDAQ:TTOO (7/26/2024, 7:03:52 PM)
After market: 5.08 -0.01 (-0.2%)5.09
+0.26 (+5.38%)
Company Profile
T2 Biosystems, Inc. engages in the development of a proprietary technology platform. The company is headquartered in Lexington, Massachusetts and currently employs 113 full-time employees. The company went IPO on 2014-08-07. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The firm's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. The company also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.
Company Info
T2 BIOSYSTEMS INC
101 Hartwell Ave
Lexington MASSACHUSETTS 02421
P: 17814571200
CEO: John Sperzel
Employees: 113
Website: https://www.t2biosystems.com/
TTOO News
4 days ago - T2 Biosystems, Inc.T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
a month ago - T2 Biosystems, Inc.T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau DistributorLEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
2 months ago - T2 Biosystems, Inc.T2 Biosystems Regains Compliance with Nasdaq Continued Listing RequirementsLEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...
2 months ago - T2 Biosystems, Inc.T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq RulesLEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...
2 months ago - T2 Biosystems, Inc.T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common StockLEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...
3 months ago - T2 Biosystems, Inc.T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseAdvances plan to launch T2Lyme Panel for detection of early Lyme disease...
TTOO Twits
Here you can normally see the latest stock twits on TTOO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
